Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.87
-0.83 (-9.54%)
At close: Jun 27, 2025, 4:00 PM
7.75
-0.12 (-1.51%)
After-hours: Jun 27, 2025, 7:56 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $253.38 million as of June 27, 2025. Its market cap has increased by 62.69% in one year.
Market Cap
253.38M
Enterprise Value
108.85M
1-Year Change
62.69%
Ranking
Category
Stock Price
$7.87
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $253.38M, a decrease of -28.58%. That is a compound annual growth rate of -15.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 280.10M | 93.33% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |